Symptoms include sharp abdominal pain, pain near the shoulder blades, jaundice, dark urine, clay-colored stool, and gastrointestinal discomfort such as nausea, bloating, and vomiting
Semaglutide promotes weight loss by activating insulin production (to lower blood sugar) and suppressing appetite
Omzo's primary offering is compounded medication
There are also limited data regarding HCRU in patients treated with GLP-1 RAs and SGLT2is
In addition to helping in weight loss, semaglutide helps regulate blood sugar levels, which is especially advantageous for people who are prediabetic or already have insulin resistance
Some people may lose a few pounds during the first month, while others experience more gradual progress as the medication builds in their system